Worldwide 2024 elections pose pivotal shifts in life sciences and healthcare
The outcomes of this year’s US, EU, and UK elections and their downstream effects will lead to drastic changes to…
All articles by Frankie Fattorini
Frankie Fattorini
Frankie Fattorini is a healthcare and pharmaceutical reporter. His background is in genomics research, and he has also worked in medical communications. Frankie has written freelance articles on emerging technologies and various pieces on oncology and drug development.
-
-
Minister for Science champions partnerships with private clinical sector in UK
Lord Patrick Vallance has emphasised plans for a close collaboration between the government and private sector, in line with the…
-
Lord O’Shaughnessy expresses optimism for clinical trials in the UK
Former health minister Lord James O’Shaughnessy said the UK is “building from a position of strength” as he assessed commercial…
-
Arrivo targets major depressive disorder in females after early efficacy data
Arrivo BioVentures’ SIRT6 activator SP-624 has been found to significantly reduce symptoms of major depressive disorder (MDD), but only in…
-
A slow start for self-amplifying mRNA vaccines
A year after bursting onto the scene amid the RNA renaissance, scientific challenges and regulatory resistance have held back self-amplifying…
-
Amgen and MediLink to collaborate on SCLC combination therapy
Amgen and MediLink Therapeutics have agreed to a research and supply collaboration to develop a combination therapy for extensive-stage small…
-
BMS and Prime ink potential $3.5bn deal to develop T cell therapies
Bristol Myers Squibb (BMS) has agreed to a research and licensing deal with Prime Medicine to develop ex vivo T…
-
AstraZeneca/Daiichi’s ADC shows better survival for nonsquamous NSCLC patients
New data from the TROPION-Lung01 trial show datopotamab deruxtecan treatment led to greater overall survival (OS) than docetaxel chemotherapy in…